Migraine With Aura: Contraceptive and Hormone Therapy Patterns

Research Summary

A recent study published in Pharmacoepidemiology and Drug Safety explored the use of oral contraceptives and hormone therapy among women with migraine with aura, a condition linked to increased stroke risk. Utilizing UK medical records from 2000 to 2024, the research found that 59% of reproductive-age women continued using oral contraceptives after a migraine diagnosis, with progestogen-only pills being more prevalent than combined oral contraceptives. In post-reproductive women, 45% used hormone therapy post-diagnosis, with a shift towards transdermal formulations. This study highlights the need for updated, high-quality research to better understand stroke risks associated with modern contraceptive and hormone therapies in this population.

Study Details

📄 Title: Utilization of Oral Contraceptives and Hormone Therapy for Menopause Among Female Individuals With Migraine With Aura: A Descriptive Study.

👥 Research Team: Gibbs LR et al.

📚 Published In: Pharmacoepidemiol Drug Saf

📅 Publication Date: 2025 Nov

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.